Ethan Basch

Dr. Basch is a medical oncologist and health services researcher.  His clinical expertise is prostate cancer, and his research expertise includes patient-reported outcomes, drug regulatory policy, and comparative effectiveness research.   

He  is a federally appointed member of the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI), a member of the Board of Directors of the International Society for Quality of Life Research (ISOQOL), Co-Chair of the Health Outcomes Committee of the Alliance for Clinical Trials in Oncology, and a member of the Board of Scientific Advisors of the National Cancer Institute.  He leads an ongoing NCI initiative to develop a patient-reported adverse event monitoring system for use in clinical research (the “PRO-CTCAE”), and is study chair for multiple trials employing patient-reported endpoints.

1989                  Phi Beta Kappa, Magna cum laude
1989                  Baker Research Fellowship, Brown University
1989                  Fulbright Scholarship
1996                  Albert Schweitz Fellowship  
1996                  Lally Research Scholarship, Harvard University
1997                  Collins Research Award, Harvard Medical School
2004 – 2006      Merit Awards, American Society of Clinical Oncology
2004                  Carbone Young Investigator Award, Geriatric                 Oncology Consortium
2004                  Research Investigator Award, Cancer and Leukemia Group B
2006                  Career Development Award, American Society of Clinical Oncology
2011                  Federal Appointee, Patient-Centered Outcomes Research Institute (PCORI), Methodology Committee
2011                  Board of Directors, International Society for Quality of Life Research
2012                  Visiting Professor, Johns Hopkins School of Medicine
2012                  Appointee, Board of Scientific Advisors, National Cancer Institute